Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
Stein
B
B
Mount Sinai Medical Center, New York, New York 10029.
Fuster
V
V
Halperin
J L
JL
Chesebro
J H
JH
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006331:Heart Diseases / Q000150:complications*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D011292:Premedication; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents